Impacts and Testing of the "Multi-Domains Active-Living Program (Map)" in Newly Diagnosed Operable Non-Muscle Invasive Bladder Cancer Patients–Instrumental Testing, Current Status and Effects of Combining with Ehealth-Enhanced Randomized Controlled Trial